Among the 58% of adults who say they want to lose weight, nearly one-third (32%) expect to start a prescription GLP-1 drug in 2026, which translates to an estimated 48 million American adults including 9% who say they definitely will and 23% who say they probably will
They designated these glucagon-like peptides 1 & 2 (GLP-1 and GLP-2) because their sequences bore a strong similarity to glucagon
However, studies have also found that GLP-1 therapies can result in the loss of muscle mass
Pinto LC, Falcetta MR, Rados DV, Leitao CB, Gross JL
Back Montesano, R, Schekman, R, Rothman, J, Perrelet, A (7 Jan 2020) 'In Memoriam: Leilo Orci, 1937-2019', Proceedings of the National Academy of Sciences , 117/1, 15-17
For more on building a sustainable eating approach, see What Fits You Best in a Diet